BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 20117437)

  • 1. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
    Lakdawala NK; Dellefave L; Redwood CS; Sparks E; Cirino AL; Depalma S; Colan SD; Funke B; Zimmerman RS; Robinson P; Watkins H; Seidman CE; Seidman JG; McNally EM; Ho CY
    J Am Coll Cardiol; 2010 Jan; 55(4):320-9. PubMed ID: 20117437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity.
    Memo M; Leung MC; Ward DG; dos Remedios C; Morimoto S; Zhang L; Ravenscroft G; McNamara E; Nowak KJ; Marston SB; Messer AE
    Cardiovasc Res; 2013 Jul; 99(1):65-73. PubMed ID: 23539503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.
    Kamisago M; Sharma SD; DePalma SR; Solomon S; Sharma P; McDonough B; Smoot L; Mullen MP; Woolf PK; Wigle ED; Seidman JG; Seidman CE
    N Engl J Med; 2000 Dec; 343(23):1688-96. PubMed ID: 11106718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
    Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
    DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca
    Robinson P; Sparrow AJ; Patel S; Malinowska M; Reilly SN; Zhang YH; Casadei B; Watkins H; Redwood C
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H306-H319. PubMed ID: 32618513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy.
    Lakdawala NK; Thune JJ; Colan SD; Cirino AL; Farrohi F; Rivero J; McDonough B; Sparks E; Orav EJ; Seidman JG; Seidman CE; Ho CY
    Circ Cardiovasc Genet; 2012 Oct; 5(5):503-10. PubMed ID: 22949430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding.
    van de Meerakker JB; Christiaans I; Barnett P; Lekanne Deprez RH; Ilgun A; Mook OR; Mannens MM; Lam J; Wilde AA; Moorman AF; Postma AV
    Biochim Biophys Acta; 2013 Apr; 1833(4):833-9. PubMed ID: 23147248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structural basis of alpha-tropomyosin linked (Asp230Asn) familial dilated cardiomyopathy.
    Lynn ML; Tal Grinspan L; Holeman TA; Jimenez J; Strom J; Tardiff JC
    J Mol Cell Cardiol; 2017 Jul; 108():127-137. PubMed ID: 28600229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutations in genes for sarcomeric proteins].
    Kimura A
    Nihon Rinsho; 2000 Jan; 58(1):117-22. PubMed ID: 10885298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of sarcomere gene mutation in patients with dilated cardiomyopathy.
    Li YD; Ji YT; Zhou XH; Li HL; Zhang HT; Zhang Y; Li JX; Xing Q; Zhang JH; Hong YF; Tang BP
    Genet Mol Res; 2015 Sep; 14(3):11200-10. PubMed ID: 26400351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
    Robinson P; Griffiths PJ; Watkins H; Redwood CS
    Circ Res; 2007 Dec; 101(12):1266-73. PubMed ID: 17932326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy.
    Carballo S; Robinson P; Otway R; Fatkin D; Jongbloed JD; de Jonge N; Blair E; van Tintelen JP; Redwood C; Watkins H
    Circ Res; 2009 Aug; 105(4):375-82. PubMed ID: 19590045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype.
    Mirza M; Marston S; Willott R; Ashley C; Mogensen J; McKenna W; Robinson P; Redwood C; Watkins H
    J Biol Chem; 2005 Aug; 280(31):28498-506. PubMed ID: 15923195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of tropomyosin-κ induces dilated cardiomyopathy and depresses cardiac myofilament tension by mechanisms involving cross-bridge dependent activation and altered tropomyosin phosphorylation.
    Karam CN; Warren CM; Rajan S; de Tombe PP; Wieczorek DF; Solaro RJ
    J Muscle Res Cell Motil; 2011 Mar; 31(5-6):315-22. PubMed ID: 21221740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy.
    Daehmlow S; Erdmann J; Knueppel T; Gille C; Froemmel C; Hummel M; Hetzer R; Regitz-Zagrosek V
    Biochem Biophys Res Commun; 2002 Oct; 298(1):116-20. PubMed ID: 12379228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy.
    Kärkkäinen S; Heliö T; Jääskeläinen P; Miettinen R; Tuomainen P; Ylitalo K; Kaartinen M; Reissell E; Toivonen L; Nieminen MS; Kuusisto J; Laakso M; Peuhkurinen K
    Eur J Heart Fail; 2004 Dec; 6(7):861-8. PubMed ID: 15556047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.
    Karibe A; Tobacman LS; Strand J; Butters C; Back N; Bachinski LL; Arai AE; Ortiz A; Roberts R; Homsher E; Fananapazir L
    Circulation; 2001 Jan; 103(1):65-71. PubMed ID: 11136687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype.
    Probst S; Oechslin E; Schuler P; Greutmann M; Boyé P; Knirsch W; Berger F; Thierfelder L; Jenni R; Klaassen S
    Circ Cardiovasc Genet; 2011 Aug; 4(4):367-74. PubMed ID: 21551322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.